tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,824 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 128.47, while Biogen’s (BIIB) share price is $127.31, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 128.51, while Biogen’s (BIIB) share price is $127.31, making it a Sell.

Biogen (BIIB) Pivot Points

Jun 26, 2025, 03:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
122.76
123.89
125.10
126.23
127.44
128.57
129.78
Fibonacci
123.89
124.78
125.34
126.23
127.12
127.68
128.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Jun 26, 2025, 03:54 PM
Period
Simple
Exponential
MA5
126.39Buy
127.00Buy
MA10
128.56Sell
128.03Sell
MA20
130.18Sell
128.47Sell
MA50
124.95Buy
128.51Sell
MA100
131.41Sell
134.30Sell
MA200
150.35Sell
154.18Sell
Biogen’s (BIIB) 10-Day exponential moving average is 128.03, while Biogen’s (BIIB) share price is $127.31, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 134.30, while Biogen’s (BIIB) share price is $127.31, making it a Sell.
Biogen’s (BIIB) stock price is $127.31 and Biogen’s (BIIB) 50-day simple moving average is 124.95, creating a Buy signal.
Biogen’s (BIIB) stock price is $127.31 and Biogen’s (BIIB) 100-day simple moving average is 131.41, creating a Sell signal.
Biogen’s (BIIB) stock price is $127.31 and Biogen’s (BIIB) 200-day simple moving average is 150.35, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Jun 26, 2025, 03:54 PM
Name
Value
Implied Action
RSI (14)
47.81
Neutral
STOCH (9,6)
24.15
Neutral
STOCHRSI (14)
21.40
Neutral
MACD (12,26)
-0.02
Buy
ADX (14)
17.51
Buy
Williams %R
-69.92
Buy
CCI (14)
-97.00
Neutral
ATR (14)
3.30
-
Ultimate Oscillator
44.71
Neutral
ROC
-3.45
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 47.81, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 17.51, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -97.00, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -3.45, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 47.81, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -0.02, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 126.39, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 130.18, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 124.95, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 150.35, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -69.92, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -97.00, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis